ALS Center
  • Home
  • About ALS
    • About ALS
    • ALS Treatment Options
    • ALS Symptom Management
    • Frequently Asked Questions
    • Living with ALS
    • Everyday Life with ALS
  • Patient Care
    • The Clinic Experience
    • Multi Disciplinary Care
  • Research
    • Active Studies
    • Research Highlights
    • Research Teams
    • Other Resources
  • About Us
    • Our History
    • Our Team
    • News and Events
  • Donate
  • Contact
Select Page
UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

by Michael Benatar | May 19, 2020 | Press Releases

May 8, 2020 (University Of Miami press release) “Therapy development for ALS is challenging for many reasons,” said Michael Benatar, M.D., Ph.D., professor of neurology, the Walter Bradley Chair in ALS Research, and executive director of the ALS Center at the...

Recent Posts

  • CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS
  • Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases
  • Learn how you can contribute to ALS research by donating CSF
  • Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
  • ALS Center investigators host first international Pre-Symptomatic ALS Workshop
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress